If a pharmacy has entered into a collaborative pharmacy practice agreement with one or more physicians pursuant to section 12-280-602 to administer injectable antagonist medication for medication-assisted treatment for substance use disorders, the pharmacy administering the drug shall receive an enhanced dispensing fee that aligns with the administration fee paid to a provider in a clinical setting.
Source: L. 2018: Entire section added, (HB 18-1007), ch. 225, p. 1433, § 7, effective January 1, 2019. L. 2019: Entire section amended, (HB 19-1172), ch. 136, p. 1710, § 188, effective October 1.
Structure Colorado Code
Title 25.5 - Health Care Policy and Financing
Article 5 - Colorado Medical Assistance Act - Services and Programs
§ 25.5-5-500.3. Authorization to Bill Third Party
§ 25.5-5-501. Providers - Drug Reimbursement
§ 25.5-5-502. Unused Medications - Reuse - Rules - Definition
§ 25.5-5-503. Prescription Drug Benefits - Authorization - Dual-Eligible Participation
§ 25.5-5-504. Providers of Pharmaceutical Services
§ 25.5-5-505. Prescribed Drugs - Mail Order - Rules
§ 25.5-5-506. Prescribed Drugs - Utilization Review
§ 25.5-5-507. Prescription Drug Information and Technical Assistance Program - Rules
§ 25.5-5-509. Substance Use Disorder - Prescription Drugs
§ 25.5-5-510. Pharmacy Reimbursement - Substance Use Disorder - Injections
§ 25.5-5-511. Reimbursement for Pharmacists' Services - Legislative Declaration
§ 25.5-5-512. Pharmacy Benefit - Mental Health and Substance Use Disorders - Legislative Declaration